Both in vitro and in vivo experiments have indicated that the downregulation of OXCT1 significantly enhanced tumor migration and metastasis, suggesting a potential tumor-suppressive role for OXCT1 in the progression of CRLM. Here, OXCT1 is linked to neoplasm.